Residual Corticosteroid Production in Autoimmune Addison Disease
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Context: Contrary to current dogma, growing evidence suggests that some patients with autoimmune Addison disease (AAD) produce corticosteroids even years after diagnosis. Objective: To determine frequencies and clinical features of residual corticosteroid production in patients with AAD. Design: Two-staged, cross-sectional clinical study in 17 centers (Norway, Sweden, and Germany). Residual glucocorticoid (GC) production was defined as quantifiable serum cortisol and 11-deoxycortisol and residual mineralocorticoid (MC) production as quantifiable serum aldosterone and corticosterone after > 18 hours of medication fasting. Corticosteroids were analyzed by liquid chromatography–tandem mass spectrometry. Clinical variables included frequency of adrenal crises and quality of life. Peak cortisol response was evaluated by a standard 250 µg cosyntropin test. Results: Fifty-eight (30.2%) of 192 patients had residual GC production, more common in men (n = 33; P < 0.002) and in shorter disease duration (median 6 [0-44] vs 13 [0-53] years; P < 0.001). Residual MC production was found in 26 (13.5%) patients and associated with shorter disease duration (median 5.5 [0.5-26.0] vs 13 [0-53] years; P < 0.004), lower fludrocortisone replacement dosage (median 0.075 [0.050-0.120] vs 0.100 [0.028-0.300] mg; P < 0.005), and higher plasma renin concentration (median 179 [22-915] vs 47.5 [0.6-658.0] mU/L; P < 0.001). There was no significant association between residual production and frequency of adrenal crises or quality of life. None had a normal cosyntropin response, but peak cortisol strongly correlated with unstimulated cortisol (r = 0.989; P < 0.001) and plasma adrenocorticotropic hormone (ACTH; r = –0.487; P < 0.001). Conclusion: In established AAD, one-third of the patients still produce GCs even decades after diagnosis. Residual production is more common in men and in patients with shorter disease duration but is not associated with adrenal crises or quality of life.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders
Miller, W. L., & Auchus, R. J. (2011) · Endocrine Reviews · doi:10.1210/er.2010-0013 · Cited by 2,458 · cited 1×
“Importantly, the enzymes involved in conversion of the precursors to the active substances are considered unidirectional (15), precluding any synthesis of precursors from cortisol or aldosterone.”
Erichsen, M. M., Løvås, K., Skinningsrud, B., Wolff, A. B., Undlien, D. E., Svartberg, J., Fougner, K. J., Berg, T. J., Bollerslev, J., Mella, B., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1368 · Cited by 422 · cited 1×
“Finally, there are large variations in self-assessed health-related quality of life (HRQoL) in AAD that could potentially be attributed to residual production (7, 8).”
Self-citationHusebye, E. S., Allolio, B., Arlt, W., Badenhoop, K., Bensing, S., Betterle, C., Falorni, A., Gan, E. H., Hulting, A. ‐., Kasperlik‐Zaluska, A., et al. (2014) · Journal of Internal Medicine · doi:10.1111/joim.12162 · Cited by 403 · cited 1×
“For GC therapy, however, surveillance relies upon more vague clinical signs and the patient’s subjective health status (21).”
Self-citationHahner, S., Loeffler, M., Bleicken, B., Drechsler, C., Milovanovic, D., Fassnacht, M., Ventz, M., Quinkler, M., & Allolio, B. (2010) · European Journal of Endocrinology · doi:10.1530/eje-09-0884 · Cited by 346
Self-citationEngels, M., Span, P. N., van Herwaarden, A. E., Sweep, F. C. G. J., Stikkelbroeck, N. M. M. L., & Claahsen-van der Grinten, H. L. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00258 · Cited by 163 · cited 1×
“The observed male preponderance in residual GC production opens for a tantalizing link to hormone-producing testicular adrenal rest tumors (TARTs), as seen in approximately 40% of men with congenital adrenal hyperplasia (29).”
Øksnes, M., Bensing, S., Hulting, A.-L., Kämpe, O., Hackemann, A., Meyer, G., Badenhoop, K., Betterle, C., Parolo, A., Giordano, R., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1901 · Cited by 99
Self-citationQuinkler, M., Ekman, B., Zhang, P., Isidori, A. M., Murray, R. D., & on behalf of the EU‐AIR Investigators (2018) · Clinical Endocrinology · doi:10.1111/cen.13609 · Cited by 71 · cited 4×
“005), higher PRC (median 179 [22-915] vs 47.”
InfluentialSelf-citationThe short cosyntropin test revisited: new normal reference range using LC-MS/MS
Ueland, G. Å., Methlie, P., Øksnes, M., Thordarson, H. B., Sagen, J., Kellmann, R., Mellgren, G., Ræder, M., Dahlqvist, P., Dahl, S. R., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-02602 · Cited by 71 · cited 2×
“A normal response was defined as peak cortisol exceeding 412 or 485 nmol/L after 30 or 60 minutes, respectively (9).”
Self-citationIncreased Infection Risk in Addison’s Disease and Congenital Adrenal Hyperplasia
Tresoldi, A. S., Sumilo, D., Perrins, M., Toulis, K. A., Prete, A., Reddy, N., Wass, J. A. H., Arlt, W., & Nirantharakumar, K. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz006 · Cited by 65
Pofi, R., Prete, A., Thornton-Jones, V., Bryce, J., Ali, S. R., Faisal Ahmed, S., Balsamo, A., Baronio, F., Cannuccia, A., Guven, A., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz055 · Cited by 53
Adrenal Steroidogenesis after B Lymphocyte Depletion Therapy in New-Onset Addison's Disease
Pearce, S. H. S., Mitchell, A. L., Bennett, S., King, P., Chandran, S., Nag, S., Chen, S., Smith, B. R., Isaacs, J. D., & Vaidya, B. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1680 · Cited by 41
Gan, E. H., MacArthur, K., Mitchell, A. L., Hughes, B. A., Perros, P., Ball, S. G., James, R. A., Quinton, R., Chen, S., Furmaniak, J., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2449 · Cited by 36 · cited 2×
“In line with previous studies, none of the patients in the current study had a normal response to the cosyntropin test (2, 4, 25, 26).”
Cited by
Husebye, E. S., Pearce, S. H., Krone, N. P., & Kämpe, O. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00136-7 · Cited by 378
Self-citationHahner, S., Ross, R. J., Arlt, W., Bancos, I., Burger-Stritt, S., Torpy, D. J., Husebye, E. S., & Quinkler, M. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00252-7 · Cited by 223
Self-citationHigh-resolution daily profiles of tissue adrenal steroids by portable automated collection
Upton, T. J., Zavala, E., Methlie, P., Kämpe, O., Tsagarakis, S., Øksnes, M., Bensing, S., Vassiliadi, D. A., Grytaas, M. A., Botusan, I. R., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.adg8464 · Cited by 94
Self-citationChantzichristos, D., Svensson, P.-A., Garner, T., Glad, C. A., Walker, B. R., Bergthorsdottir, R., Ragnarsson, O., Trimpou, P., Stimson, R. H., Borresen, S. W., et al. (2021) · eLife · doi:10.7554/elife.62236 · Cited by 36
Sævik, Å. B., Wolff, A. B., Björnsdottir, S., Simunkova, K., Hynne, M. S., Dolan, D. W. P., Bratland, E., Knappskog, P. M., Methlie, P., Carlsen, S., et al. (2021) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaa202 · Cited by 19
“We propose that this patient had residual GC production, which we recently demonstrated is present in one-third of all patients with AAD [36].”
BackgroundSelf-citation
Metadata
- Authors
- Sævik, Å. B., Åkerman, A.-K., Methlie, P., Quinkler, M., Jørgensen, A. P., Höybye, C., Debowska, A. J., Nedrebø, B. G., Dahle, A. L., Carlsen, S., Tomkowicz, A., Sollid, S. T., Nermoen, I., Grønning, K., Dahlqvist, P., Grimnes, G., Skov, J., Finnes, T., Valland, S. F., Wahlberg, J., Holte, S. E., Simunkova, K., Kämpe, O., Husebye, E. S., Bensing, S., & øksnes, M.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2020-05-11
- Volume
- 105
- Issue
- 7
- Pages
- 2430-2441
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W3022077104
- Cited by
- 28
- References
- 12
- FWCI
- 2.71
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.